EXOSTEM BIOTEC LTD has a total of 34 patent applications. It decreased the IP activity by 65.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are OLIX PHARMACEUTICALS INC, SANBIO INC and GENESENSE TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Brodie Chaya | 32 |
#2 | Brodie Shlomit | 19 |
#3 | Brodie Aharon | 8 |
#4 | Chaya Brodie | 2 |
#5 | Shlomit Brodie | 2 |
#6 | Slavin Shimon | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020212996A1 | Differentiated and nondifferentiated msc compositions and use thereof | |
WO2020016900A1 | Msc- and exosome-based immunotherapy | |
US2019015453A1 | MicroRNAS FOR THE GENERATION OF ASTROCYTES | |
AU2018270408A1 | Methods of inhibiting aging and treating aging-related disorders | |
CN110402146A | Mescenchymal stem cell group, its product and application thereof | |
US2018105797A1 | Methods of generating oligodendrocytes and cell populations comprising same | |
CN109477072A | Mescenchymal stem cell and its purposes for treating muscle damage and muscle related disease | |
US2019194622A1 | Generation of cancer stem cells and use thereof |